Rafferty Asset Management’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $783K | Buy |
|
|||||
|
2024
Q3 | $887K | Sell |
|
|||||
|
2024
Q2 | $1.36M | Sell |
|
|||||
|
2024
Q1 | $4.43M | Buy |
|
|||||
|
2023
Q4 | $735K | Sell |
|
|||||
|
2023
Q3 | $2.87M | Buy |
|
|||||
|
2023
Q2 | $4.4M | Buy |
|
|||||
|
2023
Q1 | $3.34M | Sell |
|
|||||
|
2022
Q4 | $4.76M | Buy |
|
|||||
|
2022
Q3 | $4.97M | Buy |
|
|||||
|
2022
Q2 | $2.53M | Sell |
|
|||||
|
2022
Q1 | $5.17M | Buy |
|
|||||
|
2021
Q4 | $4.41M | Buy |
|
|||||
|
2021
Q3 | $3.37M | Buy |
|
|||||
|
2021
Q2 | $2.61M | Buy |
|
|||||
|
2021
Q1 | $3.06M | Buy |
|
|||||
|
2020
Q4 | $858K | Sell |
|
|||||
|
2020
Q3 | $2.31M | Buy |
|
|||||
|
2020
Q2 | $978K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $1.26M | Sell |
|
|||||
|
2019
Q3 | $1.62M | Sell |
|
|||||
|
2019
Q2 | $2.05M | Buy |
|
|||||
|
2019
Q1 | $1.58M | Buy |
|